|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen WQ, Zheng RS, Zhang SW, Li N, Zhao P,
Li GL, Wu LY and He J: Report of incidence and mortality in china
cancer registries, 2008. Chin J Cancer Res. 24:171–180. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stavraka C and Blagden S: The La-related
proteins, a family with connections to cancer. Biomolecules.
5:2701–2722. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burrows C, Latip Abd N, Lam SJ, Carpenter
L, Sawicka K, Tzolovsky G, Gabra H, Bushell M, Glover DM, Willis
AE, et al: The RNA binding protein Larp1 regulates cell division,
apoptosis and cell migration. Nucleic Acids Res. 38:5542–5553.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mura M, Hopkins TG, Michael T, Abd-Latip
N, Weir J, Aboagye E, Mauri F, Jameson C, Sturge J, Gabra H, et al:
LARP1 post-transcriptionally regulates mTOR and contributes to
cancer progression. Oncogene. 34:5025–5036. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie C, Huang L, Xie S, Xie D, Zhang G,
Wang P, Peng L and Gao Z: LARP1 predict the prognosis for
early-stage and AFP-normal hepatocellular carcinoma. J Transl Med.
11:2722013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kato M, Goto Y, Matsushita R, Kurozumi A,
Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M,
Ichikawa T, et al: MicroRNA-26a/b directly regulate
La-related protein 1 and inhibit cancer cell invasion in prostate
cancer. Int J Oncol. 47:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li XJ, Luo XQ, Han BW, Duan FT, Wei PP and
Chen YQ: MicroRNA-100/99a, deregulated in acute lymphoblastic
leukaemia, suppress proliferation and promote apoptosis by
regulating the FKBP51 and IGF1R/mTOR signalling pathways. Br J
Cancer. 109:2189–2198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe
TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al:
Genomic profiling of microRNA and messenger RNA reveals deregulated
microRNA expression in prostate cancer. Cancer Res. 68:6162–6170.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Munker R and Calin GA: MicroRNA profiling
in cancer. Clin Sci. 121:141–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu X, Wang W, Su N, Zhu X, Yao J, Gao W,
Hu Z and Sun Y: miR-374a promotes cell proliferation, migration and
invasion by targeting SRCIN1 in gastric cancer. FEBS Lett.
589:407–413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
|
13
|
Võsa U, Vooder T, Kolde R, Fischer K, Välk
K, Tõnisson N, Roosipuu R, Vilo J, Metspalu A and Annilo T:
Identification of miR-374a as a prognostic marker for survival in
patients with early-stage nonsmall cell lung cancer. Genes
Chromosomes Cancer. 50:812–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu H, Liu Y, Shu XO and Cai Q: MiR-374a
suppresses lung adenocarcinoma cell proliferation and invasion by
targeting TGFA gene expression. Carcinogenesis. 37:567–575.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Riemenschneider MJ, Betensky RA, Pasedag
SM and Louis DN: AKT activation in human glioblastomas enhances
proliferation via TSC2 and S6 kinase signaling. Cancer Res.
66:5618–5623. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiu Z, Huang C, Sun J, Qiu W, Zhang J, Li
H, Jiang T, Huang K and Cao J: RNA interference-mediated signal
transducers and activators of transcription 3 gene silencing
inhibits invasion and metastasis of human pancreatic cancer cells.
Cancer Sci. 98:1099–1106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takemoto S, Ushijima K, Kawano K,
Yamaguchi T, Terada A, Fujiyoshi N, Nishio S, Tsuda N, Ijichi M,
Kakuma T, et al: Expression of activated signal transducer and
activator of transcription-3 predicts poor prognosis in cervical
squamous-cell carcinoma. Br J Cancer. 101:967–972. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei R, Yang Q, Han B, Li Y, Yao K, Yang X,
Chen Z, Yang S, Zhou J, Li M, et al: microRNA-375 inhibits
colorectal cancer cells proliferation by downregulating JAK2/STAT3
and MAP3K8/ERK signaling pathways. Oncotarget. 8:16633–16641.
2017.PubMed/NCBI
|
|
19
|
Cheng N and Wang GH: miR-133b, a microRNA
targeting S1PR1, suppresses nasopharyngeal carcinoma cell
proliferation. Exp Ther Med. 11:1469–1474. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ye L, Lin ST, Mi YS, Liu Y, Ma Y, Sun HM,
Peng ZH and Fan JW: Overexpression of LARP1 predicts poor prognosis
of colorectal cancer and is expected to be a potential therapeutic
target. Tumour Biol. 37:14585–14594. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tcherkezian J, Cargnello M, Romeo Y,
Huttlin EL, Lavoie G, Gygi SP and Roux PP: Proteomic analysis of
cap-dependent translation identifies LARP1 as a key regulator of
5′TOP mRNA translation. Genes Dev. 28:357–371. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sandler AB: Molecular targeted agents in
non-small-cell lung cancer. Clin Lung Cancer. 5 Suppl 1:S22–S28.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song L, Rawal B, Nemeth JA and Haura EB:
JAK1 activates STAT3 activity in non-small-cell lung cancer cells
and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Mol Cancer Ther. 10:481–494. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chiu HC, Chou DL, Huang CT, Lin WH, Lien
TW, Yen KJ and Hsu JT: Suppression of Stat3 activity sensitizes
gefitinib-resistant non small cell lung cancer cells. Biochem
Pharmacol. 81:1263–1270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee C, Dhillon J, Wang MY, Gao Y, Hu K,
Park E, Astanehe A, Hung MC, Eirew P, Eaves CJ, et al: Targeting
YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis
via the mTOR/STAT3 pathway and suppresses tumor growth in mice.
Cancer Res. 68:8661–8666. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin YH, Wu MH, Liao CJ, Huang YH, Chi HC,
Wu SM, Chen CY, Tseng YH, Tsai CY, Chung IH, et al: Repression of
microRNA-130b by thyroid hormone enhances cell motility. J Hepatol.
62:1328–1340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sato T, Shiba-Ishii A, Kim Y, Dai T, Husni
RE, Hong J, Kano J, Sakashita S, Iijima T and Noguchi M: miR-3941:
A novel microRNA that controls IGBP1 expression and is associated
with malignant progression of lung adenocarcinoma. Cancer Sci.
108:536–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL,
Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, et al: Long non-coding
RNA XIST regulates gastric cancer progression by acting as a
molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin
Cancer Res. 35:1422016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lv GY, Miao J and Zhang XL: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
Ras-related protein RAP2B via miR-320b. Oncol Res. Apr
12–2017.(Epub ahead of print). doi:
10.3727/096504017X14920318811721. View Article : Google Scholar :
|
|
30
|
Zhang YL, Li XB, Hou YX, Fang NZ, You JC
and Zhou QH: The lncRNA XIST exhibits oncogenic properties via
regulation of miR-449a and Bcl-2 in human non-small cell lung
cancer. This article has been corrected since Advanced Online
Publication, and an erratum is also printed in this issue. Acta
Pharmacol Sin. 38:371–381. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Shen Q, Zhang X, Yang C, Cui S,
Sun Y, Wang L, Fan X and Xu S: The long non-coding RNA XIST
controls non-small cell lung cancer proliferation and invasion by
modulating miR-186-5p. Cell Physiol Biochem. 41:2221–2229. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J,
Chen L, Xi Z, Teng H, Wang Z, et al: Knockdown of long non-coding
RNA XIST exerts tumor-suppressive functions in human glioblastoma
stem cells by up-regulating miR-152. Cancer Lett. 359:75–86. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kobayashi S, Totoki Y, Soma M, Matsumoto
K, Fujihara Y, Toyoda A, Sakaki Y, Okabe M and Ishino F:
Identification of an imprinted gene cluster in the X-inactivation
center. PLoS One. 8:e712222013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chureau C, Chantalat S, Romito A, Galvani
A, Duret L, Avner P, Rougeulle C, Okabe M and Ishino F: Ftx
is a non-coding RNA which affects Xist expression and
chromatin structure within the X-inactivation center region. Hum
Mol Genet. 20:705–718. 2011. View Article : Google Scholar : PubMed/NCBI
|
